NEO
NASDAQ
$14.24
Neogenomics Inc (NEO)
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $16.22 (+13.90%)
Market Cap
$252M
Free Cash Flow Yield
-8.64%
Beta (5Y)
1.21
Price Chart
Valuation
Market Cap$252M
Forward P/E222.22
P/S1.73
P/B1.34
Profitability
Total Revenue (TTM)$727M
Gross Profit (TTM)$322M
EBITDA-$80M
Profit Margin-5.2%
Operating Margin-7%
EPS-$4.20
Financial Health
Debt-to-Equity40.9%
Free Cash Flow Yield-8.64%
Growth & Risk
Revenue 5Y CAGR+10.35%
FCF 5Y CAGR-4.65%
Beta (5Y)1.21
Sharpe Ratio1.47